Activity- and affinity-based probes as research tools — design, development and applic.

webinar

Tue, 28 Apr 2020, 16:00 CEST (Berlin)

Prof. Dr. Martin D. Witte, University of Groningen, The Netherlands

Activity- and affinity-based probes as research tools — design, development and applic.

The discovery that proteins and/or protein families of interest can be labelled selectively with chemical reagents resulted in an active research field that aims to profile the amount and activity of (a subset of) proteins in a relevant setting. For this purpose, a diverse set of so-called activity- and affinity-based probes (ABPs) have been developed nowadays. The molecular structure of these probes generally consists of a recognition element, which generates selectivity for the protein of interest, a reactive group or warhead, which facilitates covalent binding of the probe to the protein, and a reporter group, which is used for read-out purposes. The activity-based protein profiling field has matured over the past decades and these research tools are nowadays employed in both fundamental and applied settings.

During this webinar, I will introduce the basics of activity- and affinity-based protein profiling. I will describe the general design approaches for ABPs, as well as their applications. In the second part of the webinar, I will discuss novel combinatorial approaches to prepare probes and I will demonstrate how chemical probes can be combined with nanoLC-MS/MS and docking studies to map the binding sites of small molecules.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on